JeeSuk Chang, Radiation Oncologist at Yonsei Cancer Center, shared an article by Sarah Baker, et al. on X:
“Check out the 2nd analysis of SABR-5!
Honored to be part of this team.
Ultracentral tumors = distant/widespread mets PFS/OS (despite similar LC).
Re-emphasizing the importance of risk-adapted dosing and strict OAR constraints.”
The Impact of Ultracentral Tumor Location on Outcomes in Patients with Pulmonary Oligometastases: A Secondary Analysis of the Single-Arm Phase 2 SABR-5 Trial.
Authors: Sarah Baker, et al.
